Atlas Trials

Effects of Roflumilast on Insulin and Blood Sugar Levels in Prediabetic Overweight and Obese Individuals

Clinical trial NCT01862029 · COMPLETED

Trial details

NCT number
NCT01862029
Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Obesity
Start date
2013-05-22
Primary completion
2017-07-25
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.